CUSIP: 68230A106
Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,985,501
-
Share change
-
-558,425
-
Total reported value
-
$3,990,000
-
Price per share
-
$1.00
-
Number of holders
-
34
-
Value change
-
-$472,444
-
Number of buys
-
9
-
Number of sells
-
18
Institutional Holders of ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) as of Q2 2016
As of 30 Jun 2016,
ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,985,501 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., Abingworth LLP, GEODE CAPITAL MANAGEMENT, LLC, EAGLE GLOBAL ADVISORS LLC, PANAGORA ASSET MANAGEMENT INC, BlackRock Advisors LLC, A.R.T. Advisors, LLC, and NORTHERN TRUST CORP.
This page lists
34
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.